AWM Investment Company »

Nektar Therapeutics shares owned by AWM Investment Company

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by AWM Investment Company from 13F filings

Historical chart of AWM Investment Company investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by AWM Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by AWM Investment Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 40k 56.90

More positions owned by AWM Investment Company

Aehr Test Systems common (AEHR)
908 Devices common (MASS)
American Superconductor Corp common (AMSC)
BlackSky Technology common (BKSY)
Aerovironment common (AVAV)
nLight common (LASR)
Kopin Corporation common (KOPN)
ADMA Biologics common (ADMA)
Impinj common (PI)
Gilat Satellite Networks common (GILT)
ASP Isotopes common (ASPI)
Backblaze common (BLZE)
PowerFleet common (AIOT)
MDxHealth, SA common (MDXH)
Everspin Technology common (MRAM)

View all positions for AWM Investment Company

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
UBS Group

View all funds holding Nektar Therapeutics